Home › Funds › Values First Advisors, Inc. › EBS
Values First Advisors, Inc. position in EBS
EMERGENT BIOSOLUTIONS INC · Health Care
Values First Advisors, Inc. reported holding 296,098 shares of EBS (EMERGENT BIOSOLUTIONS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.92% of its reported portfolio and ranking #32 among its reported holdings. Values First Advisors, Inc. has disclosed EBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Values First Advisors, Inc.'s EBS position evolved
Values First Advisors, Inc. first disclosed a stake in EBS in Q3 2023 at 152,699 shares (US$519K). The position peaked in Q3 2024 at 456,208 shares, worth US$3.8M. Across 13 filings, Values First Advisors, Inc. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 296,098 shares valued at US$2.0M — a reduction of -5,390 shares quarter over quarter.. Notable position changes include a 102% increase in Q4 2023 (shares rose 5% over the following quarter), a 53% increase in Q1 2024 (shares rose 170% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 152.70K | $519.18K | New |
| Q4 2023 | 307.89K | $738.94K | Add |
| Q1 2024 | 470.09K | $1.19M | Add |
| Q2 2024 | 466.15K | $3.18M | Reduce |
| Q3 2024 | 456.21K | $3.81M | Reduce |
| Q4 2024 | 376.69K | $3.60M | Reduce |
| Q1 2025 | 375.25K | $1.81M | Hold |
| Q2 2025 | 376.00K | $2.40M | Hold |
| Q3 2025 | 367.92K | $3.25M | Reduce |
| Q4 2025 | 305.05K | $3.77M | Reduce |
| Q1 2026 | 307.88K | $2.56M | Add |
| Q2 2026 | 301.49K | $2.53M | Reduce |
| Q3 2026 | 296.10K | $1.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EBS and 13F data
EBS (EMERGENT BIOSOLUTIONS INC) is a Health Care company. 24 other funds we track also report a position in EBS — the largest reported positions include OAK HILL ADVISORS LP (US$9.3M), PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (US$7.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EBS
- OAK HILL ADVISORS LP 1.11M sh · $9.33M · Q2 2026
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 1.14M sh · $7.55M · Q3 2026
More on Values First Advisors, Inc.
FAQ
How long has Values First Advisors, Inc. held EBS?
Values First Advisors, Inc. has disclosed EBS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Values First Advisors, Inc.'s current position in EBS?
As of Q3 2026, Values First Advisors, Inc. holds 296.10K shares of EBS (EMERGENT BIOSOLUTIONS INC), valued at $1.95M, representing 0.92% of its reported portfolio and ranking #32.
Has Values First Advisors, Inc. been buying or selling EBS?
In the latest 13F filing (Q3 2026), Values First Advisors, Inc. reduced its position in EBS. The position peaked in Q3 2024 at 456.21K shares.
Which other funds hold EBS?
Other major institutional holders of EBS include OAK HILL ADVISORS LP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.